Paul LaViolette
Managing Partner & COO, SV Health Investors and Innovation Growth Board Chairman
Paul LaViolette is Managing Partner & COO at SV Health Investors. He brings over 34 years of global medical technology management experience. Paul was most recently Chief Operating Officer at – …
Earl (Duke) Collier
President, The Braxton Company and Innovation Growth Board Chairman Emeritus
Duke Collier served from 2010-2014 as the Chief Executive Officer of 480 Biomedical, a medical device company developing products used in the treatment of peripheral artery disease, and the executive – …
Joe Cunningham, MD
Managing Director, Santé Ventures
Joe Cunningham is a Founding Partner and Managing Director of Santé Ventures, an early stage life science and healthcare venture capital company based in Austin and Houston, Texas. Prior to – …
Jean-François Formela, MD
Partner, Atlas Venture
Jean-François Formela focuses on new advances in biology and drug discovery technologies as well as novel therapeutics. He is chair of the board of IFM Therapeutics and KDAC Therapeutics, and – …
Michael Greeley
General Partner, Flare Capital Partners
Michael is a General Partner at Flare Capital Mass General Brigham. Prior to co-founding Flare Capital Mass General Brigham, Michael was the founding General Partner of Flybridge Capital Mass General – …
Adele Gulfo
Chief of Commercial Development, Roivant Sciences
Adele Gulfo is the Chief of Commercial Development, Roivant Sciences. Previously, she served as Chief Strategy Officer, EVP and Head of Global Commercial Development at Mylan. She is currently a – …
Reid Huber, PhD
Partner. Third Rock Ventures
Dr. Huber joined Third Rock Ventures in 2018 as Partner. Third Rock is one of the industries preeminent life sciences company creation firms based in Boston, MA. At Third Rock, – …
Keith Kerman, MD
Senior Advisor & Operating Partner, The Riverside Company
Keith Kerman, MD is a Senior Advisor and Operating Partner with The Riverside Company, a global private equity firm focused on middle market growth businesses. Dr. Kerman has been an – …
Adam Koppel, MD, PhD
Managing Director, Bain Capital Life Sciences Fund
Adam Koppel rejoined Bain Capital in 2016 as Managing Director of the Bain Capital Life Sciences Fund. He had initially joined Bain Capital Public Equity in 2003 where he was – …
John Lepore, MD
SVP, R&D Pipeline GlaxoSmithKline
John Lepore is SVP for R&D Pipeline at GlaxoSmithKline, where his group is responsible for R&D activities across neuroscience, rare diseases, respiratory, and metabolic and cardiovascular disease. His group is – …
Barbara Lubash
Barbara Lubash is a Director and Advisor for corporate and non-profit boards. She serves on the boards of Advanced ICU Care, CareConnectMD, Clew Medical, and the Solve ME/CFS (Chronic Fatigue – …
Amir Nashat
Managing Partner, Polaris
Amir Nashat is a managing partner in Polaris’ Boston office. Amir joined Polaris in April 2002 and focuses on investments in healthcare, consumer products and energy.Amir currently represents Polaris as – …
Russ Richmond, MD
Russ Richmond, MD, is a physician and entrepreneur with experience building subscription data-analytics companies such as Advanced Practice Strategies (APS), Validic, PeraHealth, Explorys, Objective Health, Verisk Health, and D2Hawkeye, as – …
Alfred Sandrock, MD, PhD
CEO, Voyager Therapeutics
Dr. Sandrock has been CEO of Voyager and a Board member since 2022. Dr. Sandrock joined Voyager following a prolific career in biopharmaceutical drug development, in which he spent 23 – …
Sue Siegel
Sue Siegel has driven game-changing ideas and powered companies that advance industries and improve lives for more than three decades. With vast experience across industries, she is on the forefront – …
Paula Ness Speers
Partner and Managing Director, Health Advances
Paula Ness Spears co-founded Health Advances over 25 years ago, and now advises senior level client engagements focused on strategies to evaluate and optimize the value of developmental and marketed – …
